Z Orthop Unfall 2015; 153(05): 498-507
DOI: 10.1055/s-0035-1545902
Leitlinien
Georg Thieme Verlag KG Stuttgart · New York

S3-Leitlinie. Teil 3: Atraumatische Femurkopfnekrose des Erwachsenen – Operative Therapie der atraumatischen Femurkopfnekrose des Erwachsenen

S3 Guideline. Part 3: Non-Traumatic Avascular Necrosis in Adults – Surgical Treatment of Atraumatic Avascular Femoral Head Necrosis in Adults
U. Maus
1   Klinik für Orthopädie und orthopädische Chirurgie, Universitätsklinik für Orthopädie und Unfallchirurgie, Pius-Hospital, Oldenburg
,
A. Roth
2   Klinik und Poliklinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Universitätsklinik Leipzig AöR
,
M. Tingart
3   Orthopaedic Surgery, University of Aachen
,
C. Rader
4   Praxisklinik Orthopädie Aachen, Franziskushospital Aachen
,
M. Jäger
5   Klinik für Orthopädie und Unfallchirurgie, Universität Duisburg-Essen
,
U. Nöth
6   Klinik für Orthopädie und Unfallchirurgie, Evangelisches Waldkrankenhaus Spandau
,
S. Reppenhagen
7   Orthopädische Klinik König-Ludwig-Haus, Julius-Maximilians-Universität Würzburg
,
C. Heiss
8   Klinik für Unfallchirurgie, Universitätsklinikum Gießen
,
J. Beckmann
9   Sektion Endoprothetik, Sportklinik Stuttgart
› Author Affiliations
Further Information

Publication History

Publication Date:
05 August 2015 (online)

Zusammenfassung

Der Artikel beschreibt die Leitlinien der operativen Therapie der atraumatischen Femurkopfnekrose (aFKN). Diese umfassen gelenkerhaltende und gelenkersetzende Verfahren. Im Rahmen der gezielten Literaturrecherche konnten 43 Publikationen zur Bewertung der operativen Therapie eingeschlossen und ausgewertet werden. Entsprechend der GRADE- und SIGN-Kriterien werden Level of Evidence (LoE), Empfehlungsgrad (EG) und Expertenkonsens (EK) zu jeder Aussage und Fragestellung aufgeführt. Die ausgewerteten Studien konnten zeigen, dass bis zu einem ARCO-Stadium III einschließlich gelenkerhaltend operiert werden kann. Ein bestimmter gelenkerhaltender Eingriff kann derzeit nicht bevorzugt empfohlen werden. Die Auswahl des Verfahrens ist abhängig von der Ausdehnung der Nekrose. Die Core-Dekompression soll in den Stadien ARCO I (reversibles Frühstadium) oder Stadium ARCO II (irreversibles Frühstadium) mit medialer oder zentraler Nekrose mit einer Ausdehnung von weniger als 30 % des Hüftkopfs durchgeführt werden und zeigt hier bessere Ergebnisse als die konservative Therapie. In Stadium ARCO III mit Infraktion des Hüftkopfs kann die Core-Dekompression zur kurzfristigen Schmerzreduktion eingesetzt werden. Ab einem ARCO-Stadium IIIC oder in Stadium IV sollte keine Core-Dekompression mehr erfolgen. In diesen Fällen sollte die Indikation zur Implantation einer Hüft-TEP überprüft werden. Weitere Therapieverfahren (z. B. Osteotomien) sowie innovative Behandlungsoptionen (advanced core decompression, autologes Knochenmark, Spongiosaplastik u. a.) können im Einzelfall diskutiert werden. Beim elektiven Hüftgelenksersatz sind die Komplikations- und damit Revisionsraten seit Jahrzehnten deutlich rückläufig. Im Fall einer zugrunde liegenden aFKN können jedoch vorangegangene gelenkerhaltende Voroperationen (insbesondere Umstellungen und Grafts) die Implantation einer HTEP deutlich erschweren. Die Implantatstandzeit scheint jedoch auch von der Ätiologie abhängig zu sein. Höhere Revisionsraten für Femurkopfnekrose sind insbesondere zu erwarten bei Sichelzellanämie, Morbus Gaucher oder nach Nierentransplantation. Ferner ist das relativ junge Alter von Patienten mit Femurkopfnekrose als Hauptrisikofaktor der höheren Revisionsrate zu werten. Die Ergebnisse nach Oberflächenersatz (mit heute bekannter zurückhaltender Indikationsstellung) und zementierter wie zementfreier HTEP bei aFKN sind bei korrekter Indikationsstellung vergleichbar mit denen bei Koxarthrose oder anderen Diagnosen. Unabhängig von der zugrunde liegenden Erkrankung führt die endoprothetische Versorgung bei aFKN endoprothetisch zu guten Ergebnissen. Hierbei können sowohl zementierte als auch zementfreie Verankerungstechniken empfohlen werden.

Abstract

The present article describes the guidelines for the surgical treatment of atraumatic avascular necrosis (aFKN). These include joint preserving and joint replacement procedures. As part of the targeted literature, 43 publications were included and evaluated to assess the surgical treatment. According to the GRADE and SIGN criteria level of evidence (LoE), grade of recommendation (EC) and expert consensus (EK) were listed for each statement and question. The analysed studies have shown that up to ARCO stage III, joint-preserving surgery can be performed. A particular joint-preserving surgery currently cannot be recommended as preferred method. The selection of the method depends on the extent of necrosis. Core decompression performed in stage ARCO I (reversible early stage) or stage ARCO II (irreversible early stage) with medial or central necrosis with an area of less than 30 % of the femoral head shows better results than conservative therapy. In ARCO stage III with infraction of the femoral head, the core decompression can be used for a short-term pain relief. For ARCO stage IIIC or stage IV core decompression should not be performed. In these cases, the indication for implantation of a total hip replacement should be checked. Additional therapeutic procedures (e.g., osteotomies) and innovative treatment options (advanced core decompression, autologous bone marrow, bone grafting, etc.) can be discussed in the individual case. In elective hip replacement complications and revision rates have been clearly declining for decades. In the case of an underlying aFKN, however, previous joint-preserving surgery (osteotomies and grafts in particular) can complicate the implantation of a THA significantly. However, the implant life seems to be dependent on the aetiology. Higher revision rates for avascular necrosis are particularly expected in sickle cell disease, Gaucher disease, or kidney transplantation patients. Furthermore, the relatively young age of the patient with avascular necrosis should be seen as the main risk factor for higher revision rate. The results after resurfacing (today with known restricted indications) and cemented as well as cementless THA in aFKN are comparable for the appropriate indication to those in coxarthrosis or other diagnoses. Regardless of the underlying disease endoprosthetic treatment in aFKN leads to good results. Both cemented and cementless fixation techniques can be recommended.

 
  • Literatur

  • 1 Im GI, Kim DY, Shin JH et al. Degeneration of the acetabular cartilage in osteonecrosis of the femoral head: histopathologic examination of 15 hips. Acta Orthop Scand 2000; 71: 28-30
  • 2 Lieberman JR, Engstrom SM, Meneghini RM et al. Which factors influence preservation of the osteonecrotic femoral head?. Clin Orthop Relat Res 2012; 470: 525-534
  • 3 Kawate K, Yajima H, Sugimoto K et al. Indications for free vascularized fibular grafting for the treatment of osteonecrosis of the femoral head. BMC Musculoskelet Disord 2007; 8: 78
  • 4 Berend KR, Gunneson EE, Urbaniak JR. Free vascularized fibular grafting for the treatment of postcollapse osteonecrosis of the femoral head. J Bone Joint Surg Am 2003; 85-A: 987-993
  • 5 Yoo MC, Kim KI, Hahn CS et al. Long-term followup of vascularized fibular grafting for femoral head necrosis. Clin Orthop Relat Res 2008; 466: 1133-1140
  • 6 Fang T, Zhang EW, Sailes FC et al. Vascularized fibular grafts in patients with avascular necrosis of femoral head: a systematic review and meta-analysis. Arch Orthop Trauma Surg 2013; 133: 1-10
  • 7 Schneider W, Breitenseher M, Engel A et al. Der Stellenwert der Bohrung in der Behandlung der Hüftkopfnekrose. Orthopäde 2000; 29: 420-429
  • 8 Castro jr. FP, Barrack RL. Core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis. Am J Orthop (Belle Mead NJ) 2000; 29: 187-194
  • 9 Stulberg BN, Davis AW, Bauer TW et al. Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin Orthop Relat Res 1991; 268: 140-151
  • 10 Koo KH, Kim R, Ko GH et al. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br 1995; 77: 870-874
  • 11 Beltran J, Knight CT, Zuelzer WA et al. Core decompression for avascular necrosis of the femoral head: correlation between long-term results and preoperative MR staging. Radiology 1990; 175: 533-536
  • 12 Scully SP, Aaron RK, Urbaniak JR. Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. J Bone Joint Surg Am 1998; 80: 1270-1275
  • 13 Maniwa S, Nishikori T, Furukawa S et al. Evaluation of core decompression for early osteonecrosis of the femoral head. Arch Orthop Trauma Surg 2000; 120: 241-244
  • 14 Lavernia CJ, Sierra RJ. Core decompression in atraumatic osteonecrosis of the hip. J Arthroplasty 2000; 15: 171-178
  • 15 Saito S, Ohzono K, Ono K. Joint-preserving operations for idiopathic avascular necrosis of the femoral head. Results of core decompression, grafting and osteotomy. J Bone Joint Surg Br 1988; 70: 78-84
  • 16 Aaron RK, Steinberg ME. Electrical stimulation of osteonecrosis of the femoral head. Semin Arthroplasty 1991; 2: 214-221
  • 17 Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res 1996; 324: 169-178
  • 18 Neumayr LD, Aguilar C, Earles AN et al. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am 2006; 88: 2573-2582
  • 19 Aaron RK, Lennox D, Bunce GE et al. The conservative treatment of osteonecrosis of the femoral head. A comparison of core decompression and pulsing electromagnetic fields. Clin Orthop Relat Res 1989; 249: 209-218
  • 20 Wang CJ, Wang FS, Huang CC et al. Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am 2005; 87: 2380-2387
  • 21 Aigner N, Petje G, Schneider W et al. Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study. Wien Klin Wochenschr 2005; 117: 130-135
  • 22 Steinberg ME, Brighton CT, Corces A et al. Osteonecrosis of the femoral head. Results of core decompression and grafting with and without electrical stimulation. Clin Orthop Relat Res 1989; 249: 199-208
  • 23 Steinberg ME, Brighton CT, Bands RE et al. Capacitive coupling as an adjunctive treatment for avascular necrosis. Clin Orthop Relat Res 1990; 261: 11-18
  • 24 Steinberg ME, Brighton CT, Hayken GD et al. Electrical stimulation in the treatment of osteonecrosis of the femoral head–a 1-year follow-up. Orthop Clin North Am 1985; 16: 747-756
  • 25 Trancik T, Lunceford E, Strum D. The effect of electrical stimulation on osteonecrosis of the femoral head. Clin Orthop Relat Res 1990; 256: 120-124
  • 26 Mont MA, Jones LC, Seyler TM et al. New treatment approaches for osteonecrosis of the femoral head: an overview. Instr Course Lect 2007; 56: 197-212
  • 27 Kang P, Pei F, Shen B et al. Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study. Joint Bone Spine 2012; 79: 67-72
  • 28 Steinberg ME, Larcom PG, Strafford B et al. Core decompression with bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res 2001; 386: 71-78
  • 29 Gangji V, Hauzeur JP, Matos C et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 2004; 86-A: 1153-1160
  • 30 Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002; 405: 14-23
  • 31 Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res 2003; 417: 84-92
  • 32 Mont MA, Einhorn TA, Sponseller PD et al. The trapdoor procedure using autogenous cortical and cancellous bone grafts for osteonecrosis of the femoral head. J Bone Joint Surg Br 1998; 80: 56-62
  • 33 Kim SY, Kim YG, Kim PT et al. Vascularized compared with nonvascularized fibular grafts for large osteonecrotic lesions of the femoral head. J Bone Joint Surg Am 2005; 87: 2012-2018
  • 34 Garberina MJ, Berend KR, Gunneson EE et al. Results of free vascularized fibular grafting for femoral head osteonecrosis in patients with systemic lupus erythematosus. Orthop Clin North Am 2004; 35: 353-357
  • 35 Yen CY, Tu YK, Ma CH et al. Osteonecrosis of the femoral head: comparison of clinical results for vascularized iliac and fibula bone grafting. J Reconstr Microsurg 2006; 22: 21-24
  • 36 Chen W, Zhang F, Chang SM et al. Microsurgical fibular flap for treatment of avascular necrosis of the femoral head. J Am Coll Surg 2006; 202: 324-334
  • 37 Kane SM, Ward WA, Jordan LC et al. Vascularized fibular grafting compared with core decompression in the treatment of femoral head osteonecrosis. Orthopedics 1996; 19: 869-872
  • 38 Soucacos PN, Beris AE, Malizos K et al. Treatment of avascular necrosis of the femoral head with vascularized fibular transplant. Clin Orthop Relat Res 2001; 386: 120-130
  • 39 Yoo MC, Chung DW, Hahn CS. Free vascularized fibula grafting for the treatment of osteonecrosis of the femoral head. Clin Orthop Relat Res 1992; 277: 128-138
  • 40 Plakseychuk AY, Kim SY, Park BC et al. Vascularized compared with nonvascularized fibular grafting for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am 2003; 85-A: 589-596
  • 41 Urbaniak JR, Coogan PG, Gunneson EB et al. Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting. A long-term follow-up study of one hundred and three hips. J Bone Joint Surg Am 1995; 77: 681-694
  • 42 Eward WC, Rineer CA, Urbaniak JR et al. The vascularized fibular graft in precollapse osteonecrosis: is long-term hip preservation possible?. Clin Orthop Relat Res 2012; 470: 2819-2826
  • 43 Meyers MH. Osteonecrosis of the femoral head treated with the muscle pedicle graft. Orthop Clin North Am 1985; 16: 741-745
  • 44 Jäger M, Werner A, Lentrodt S et al. Schmerztherapie bei nichtjuvenilen, aseptischen Osteonekrosen. Schmerz 2004; 18: 481-491
  • 45 Schneider W, Aigner N, Pinggera O et al. Intertrochanteric osteotomy for avascular necrosis of the head of the femur. Survival probability of two different methods. J Bone Joint Surg Br 2002; 84: 817-824
  • 46 Hasegawa Y, Sakano S, Iwase T et al. Pedicle bone grafting versus transtrochanteric rotational osteotomy for avascular necrosis of the femoral head. J Bone Joint Surg Br 2003; 85: 191-198
  • 47 Shuler MS, Rooks MD, Roberson JR. Porous tantalum implant in early osteonecrosis of the hip: preliminary report on operative, survival, and outcomes results. J Arthroplasty 2007; 22: 26-31
  • 48 Tsao AK, Roberson JR, Christie MJ et al. Biomechanical and clinical evaluations of a porous tantalum implant for the treatment of early-stage osteonecrosis. J Bone Joint Surg Am 2005; 87 (Suppl. 02) S22-S27
  • 49 Johannson HR, Zywiel MG, Marker DR et al. Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review. Int Orthop 2011; 35: 465-473
  • 50 Kawasaki M, Hasegawa Y, Sakano S et al. Total hip arthroplasty after failed transtrochanteric rotational osteotomy for avascular necrosis of the femoral head. J Arthroplasty 2005; 20: 574-579
  • 51 Lim SJ, Moon YW, Eun SS et al. Total hip arthroplasty using the S-ROM modular stem after joint-preserving procedures for osteonecrosis of the femoral head. J Arthroplasty 2008; 23: 495-501
  • 52 Beckmann J, Rader CP, Lüring C et al. Endoprothetische Gelenkversorgung bei Hüftkopfnekrose. Osteologie 2010; 19: 46-52
  • 53 Ritter MA, Helphinstine J, Keating EM et al. Total hip arthroplasty in patients with osteonecrosis. The effect of cement techniques. Clin Orthop Relat Res 1997; 338: 94-99
  • 54 Davis ET, McKee MD, Waddell JP et al. Total hip arthroplasty following failure of free vascularized fibular graft. J Bone Joint Surg Am 2006; 88 (Suppl. 03) S110-S115
  • 55 Radl R, Hungerford M, Materna W et al. Higher failure rate and stem migration of an uncemented femoral component in patients with femoral head osteonecrosis than in patients with osteoarthrosis. Acta Orthop 2005; 76: 49-55
  • 56 Mont MA, Seyler TM, Plate JF et al. Uncemented total hip arthroplasty in young adults with osteonecrosis of the femoral head: a comparative study. J Bone Joint Surg Am 2006; 88 (Suppl. 03) S104-S109
  • 57 Stulberg BN, Fitts SM, Zadzilka JD et al. Resurfacing arthroplasty for patients with osteonecrosis. Bull NYU Hosp Jt Dis 2009; 67: 138-141
  • 58 Mont MA, Seyler TM, Marker DR et al. Use of metal-on-metal total hip resurfacing for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am 2006; 88 (Suppl. 03) S90-S97
  • 59 Beaule PE, Amstutz HC, Le Duff M et al. Surface arthroplasty for osteonecrosis of the hip: hemiresurfacing versus metal-on-metal hybrid resurfacing. J Arthroplasty 2004; 19 (8 Suppl. 3) S54-S58
  • 60 Chan YS, Shih CH. Bipolar versus total hip arthroplasty for hip osteonecrosis in the same patient. Clin Orthop Relat Res 2000; 379: 169-177
  • 61 Chiu KH, Shen WY, Ko CK et al. Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. A comparison with other diagnoses. J Arthroplasty 1997; 12: 683-688
  • 62 DʼAntonio JA, Capello WN, Manley MT et al. Hydroxyapatite coated implants. Total hip arthroplasty in the young patient and patients with avascular necrosis. Clin Orthop Relat Res 1997; 344: 124-138
  • 63 Kim YH, Oh SH, Kim JS et al. Contemporary total hip arthroplasty with and without cement in patients with osteonecrosis of the femoral head. J Bone Joint Surg Am 2003; 85-A: 675-681
  • 64 Ortiguera CJ, Pulliam IT, Cabanela ME. Total hip arthroplasty for osteonecrosis: matched-pair analysis of 188 hips with long-term follow-up. J Arthroplasty 1999; 14: 21-28